Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Serbia

Research and Innovation Action · Running

BioMeld A Modular Framework for Designing and Producing Biohybrid Machines

Coordinator
Univerzitet U Novom Sadu, Poljoprivredni Fakultet Novi Sad, Serbia
Runs
1 October 2022 to 31 March 2026
Status
Running
EU funding
€4.0m
Total cost
€4.0m
Partners
7 organisations in 5 countries
Type
Research and Innovation Action
Grant agreement
101070328

What the project is doing

In the project's own words, from its summary on CORDIS.

Bio-hybrid machines (BHMs) combine living cell actuators with artificial materials in order to achieve greater autonomy, flexibility, and energy efficiency compared to standard robots. However, BHMs are developed in silos of individual research groups, making their development more of an art relying on individual knowledge, intuition, and skills than on standardized decision-making processes. To push the manufacturing of BHMs towards bio-intelligent paradigm and model-based engineering, we propose to develop a self-monitoring and self-controlling manufacturing pipeline of BHMs.

To realize such a pipeline, we would need to (i) Develop a modeling and simulation framework that will streamline the processes of design, quoting, manufacturing, verification, and reporting, thus significantly reducing error-prone manual steps. Also, given that actuators in BHMs are living cells, which greatly expands the parameter space, we believe that the development of BHMs would greatly benefit from AI-guided modeling process to optimize search for the most efficient design; (ii) To experimentally test, optimize, and verify the platform by developing a proof-of-principle reconfigurable modular catheter BHM; (iii) To group all necessary manufacturing equipment into an integrated bio-intelligent manufacturing cell (BIMC) and demonstrate its adaptable operation.

As a proof-of-principle, we will use BHM catheter as it is an innovative medical device that would be able to arrive into hard-to-reach regions of the human body and release drugs there.

Who is involved

OrganisationCityCountryRole
Univerzitet U Novom Sadu, Poljoprivredni Fakultet Novi SadNovi SadSerbiaCoordinator
Leverette LanceUccleBelgiumParticipant
Fundacio Institut De Bioenginyeria De CatalunyaBarcelonaSpainParticipant
Scuola Superiore Di Studi Universitari E Di Perfezionamento S AnnaPisaItalyParticipant
Smart Sensing S.r.l.NapoliItalyParticipant
Universita Degli Studi Di CagliariCagliariItalyParticipant
University of the West of England, BristolBristolUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI